Veterinary Medicines

Cyclavance 100 mg/ml oral solution for dogs and cats

Authorised
  • Ciclosporin
Download as PDF

Product identification

Medicine name:
Cyclavance 100 mg/ml oral solution for dogs and cats
Cyclance vet 100 mg/ml mikstur, oppløsning til hund og katt
Active substance:
  • Ciclosporin
Target species:
  • Dog
  • Cat
Route of administration:
  • Oral use

Product details

Active substance and strength:
  • Ciclosporin
    100.00
    milligram(s)
    /
    1.00
    millilitre(s)
Pharmaceutical form:
  • Oral solution
Withdrawal period by route of administration:
  • Oral use
    • Dog
    • Cat
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QL04A
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Norway
Package description:
  • Amber glass (type III) bottles closed with a 20 mm bromobutyl stopper and an aluminum cap with flip-off.50 ml bottle, with two dispenser sets consisting of a polycarbonate dispenser capwith a silicone valve and both 1 ml and 3 ml polypropylene oral syringes graduated in increments of respectively 0.05 ml and 0.1 ml, packaged in a cardboard box.
  • Amber glass (type III) bottles closed with a 20 mm bromobutyl stopper and an aluminum cap with flip-off.30 ml bottle, with two dispenser sets consisting of a polycarbonate dispenser capwith a silicone valve and both 1 ml and 3 ml polypropylene oral syringes graduated in increments of respectively 0.05 ml and 0.1 ml, packaged in a cardboard box.
  • Amber glass (type III) bottles closed with a 20 mm bromobutyl stopper and an aluminum cap with flip-off.15 ml bottle with a dispenser set consisting of a polycarbonate dispenser cap with asilicone valve and a 1 ml polypropylene oral syringe graduated in increments of 0.05 mL, packaged in a cardboard box.
  • Amber glass (type III) bottles closed with a 20 mm bromobutyl stopper and an aluminum cap with flip-off.5 ml bottle with a dispenser set consisting of a polycarbonate dispenser cap with asilicone valve and a 1 ml polypropylene oral syringe graduated in increments of 0.05 ml, packaged in a cardboard box.
  • Amber glass (type III) bottles closed with a child resistant HDPE screw cap including aplastic adapter (HDPE).60 ml bottle, with two dispenser sets consisting of both 1 ml and 2 ml PE oralsyringes graduated in increments of respectively 0.05 ml and 0.1 ml, packaged in a cardboard box.
  • Amber glass (type III) bottles closed with a child resistant HDPE screw cap including aplastic adapter (HDPE).30 ml bottle, with two dispenser sets consisting of both 1 ml and 2 ml PE oralsyringes graduated in increments of respectively 0.05 ml and 0.1 ml, packaged in a cardboard box.
  • Amber glass (type III) bottles closed with a child resistant HDPE screw cap including aplastic adapter (HDPE).15 ml bottle, with a dispenser set consisting of a 1 ml PE oral syringe graduated inincrements of 0.05 ml, packaged in a cardboard box.
  • Amber glass (type III) bottles closed with a child resistant HDPE screw cap including aplastic adapter (HDPE).5 ml bottle, with a dispenser set consisting of a 1 ml PE oral syringe graduated inincrements of 0.05 ml, packaged in a cardboard box.

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Generic application (Article 13(1) of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Virbac
Marketing authorisation date:
Manufacturing sites for batch release:
  • Labiana Life Sciences S.A.
Responsible authority:
  • Norwegian Medical Products Agency
Authorisation number:
  • 13-9513
Date of authorisation status change:
Reference member state:
  • Ireland
Procedure number:
  • IE/V/0523/001
Concerned member states:
  • Austria
  • Belgium
  • Bulgaria
  • Cyprus
  • Czechia
  • Denmark
  • Estonia
  • Finland
  • France
  • Germany
  • Greece
  • Hungary
  • Italy
  • Latvia
  • Lithuania
  • Luxembourg
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Romania
  • Slovakia
  • Slovenia
  • Spain
  • Sweden
  • United Kingdom (Northern Ireland)

Documents

Summary of Product Characteristics

English (PDF)
Published on: 3/05/2024
Download
Norwegian (PDF)
Published on: 31/01/2024
Download

Package Leaflet

This document does not exist in this language (English). You can find it in another language below.
Norwegian (PDF)
Published on: 31/01/2024
Download
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."